Mutagenesis significantly increased medulloblastoma frequency and identified17 candidate cancer genes, including orthologs of genes somatically mutated(PTEN, CREBBP) or associated with poor outcome (PTEN,MYT1L) in the human disease. This evidence concerns the gene CREBBP and cancer.